Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 3 of 8

David Bentley, vice-president and chief scientist at Illumina, Genomic England’s sequencing partner for the 100,000 Genomes Project says there’s real actionable information coming out of the project

David Bentley, vice-president and chief scientist at Illumina, Genomic England’s sequencing partner for the 100,000 Genomes Project, says that a diagnosis often brings relief for patients with rare diseases and hope by enabling the next steps in their care

Source  Courtesy of David Bentley